Codes / ICD10CM / T37.0X5D

T37.0X5D Adverse effect of sulfonamides, subsequent encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Adverse effect of sulfonamides, subsequent encounter

Summary

This condition represents a subsequent encounter for an adverse effect caused by sulfonamide medications. It applies when a patient receives care for complications or ongoing management related to a previously identified adverse reaction to sulfonamides, following the acute phase of the event.

Causes

Adverse effects of sulfonamides may result from allergic reactions, idiosyncratic responses, or drug interactions. The subsequent encounter code is used when the patient is seen for residual effects, monitoring, or treatment of complications after the initial adverse event has been addressed.

Risk Factors

  • Prior history of sulfonamide allergy or sensitivity.
  • Concurrent use of other medications that may potentiate adverse effects.
  • Underlying conditions affecting drug metabolism or excretion.
  • Prolonged or repeated exposure to sulfonamides.

Symptoms

  • Persistent skin reactions (e.g., rashes, photosensitivity).
  • Gastrointestinal issues (e.g., nausea, diarrhea) lasting beyond the acute phase.
  • Hematologic abnormalities (e.g., blood dyscrasias) requiring ongoing monitoring.
  • Renal or hepatic dysfunction secondary to the adverse effect.

Diagnosis

Diagnosis relies on clinical correlation with the patient’s medication history and prior documentation of the adverse effect. Lab tests (e.g., blood counts, liver/kidney function) may be used to assess residual or ongoing organ involvement. The encounter must be linked to a previously established adverse reaction.

Treatment Options

Management focuses on monitoring for resolution or progression of symptoms, adjusting medications if needed, and providing supportive care. Treatment may include discontinuation of the offending agent, symptom-specific therapies, or referral to specialists for persistent complications.

Prognosis and Follow-Up

Prognosis depends on the severity of the initial adverse effect and the patient’s response to treatment. Follow-up care ensures resolution of symptoms, prevents recurrence, and addresses any long-term sequelae. Regular monitoring may be required for organ function or hematologic parameters.

Complications

  • Chronic skin conditions or scarring from severe reactions.
  • Persistent organ dysfunction (e.g., renal impairment).
  • Increased sensitivity to future sulfonamide exposure.
  • Psychological impact from the adverse event experience.

Lifestyle & Prevention

  • Avoid sulfonamide medications if prior adverse effects occurred.
  • Maintain updated medication lists to prevent unintended exposure.
  • Educate patients on recognizing early signs of adverse reactions.
  • Use alternative antibiotics when sulfonamide allergy is confirmed.

When to Seek Professional Help

Seek care if new or worsening symptoms (e.g., rash, fever, organ-related signs) develop, or if the patient experiences difficulty breathing, swelling, or severe pain. Prompt evaluation is necessary to rule out recurrent or progressive adverse effects.

Tips for Medical Coders

Document the nature of the subsequent encounter (e.g., follow-up, complication management) and confirm the prior adverse effect of sulfonamides. Ensure the encounter is not coded as acute if the event has resolved and this is a follow-up visit. Link the code to the original adverse effect for accurate sequencing.

Book a walkthrough

T37.0X5D policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.